Join us on a journey into the future of multicolor flow cytometry with FlowView Diagnostics. Introducing FlowView, the solution that brings you the next dimension in clinical decision support. Our innovative platform revolutionizes the analysis of massive raw datasets, providing rapid, standardized, and precise insights that accelerate treatment decisions.
We are thrilled to announce our participation at ESCCA Trade Show as FlowView Diagnostics, the leading provider of intelligent decision support solutions for flow cytometry.
ESCCA Trade Show brings together top researchers, industry leaders, and passionate professionals to explore the potential of flow cytometry. Whether you're an expert or new to the field, this is the perfect platform to gain invaluable insights.
Powered by AI, the asudes platform is a Clinical Decision Support Platform for Flow cytometry that helps analyzing very complex data sets, enabling care teams to save time by reducing variabilities in outcomes, reduction in processing time, and improve the lives of patients.
Powered by evidence-based AI analysis, FlowView delivers transparency from Cell to Care.
Asudes offers a pipeline where data remains data, insights remain insights and decisions become valuable.
Embedded in our asudes platform, eclipse analyses the large volumes of raw data produced by MFC and filters out all normal cells, leading to a non-crowded representation of abnormal cells, shown as simplified 2D image.
Flow cytometric evaluation of the neutrophil compartment in COVID-19 at hospital.
Optimal Transformation for flow cytometry data (Otflow) uses various statistical methods.
New method ECLIPSE (Elimination of Cell Lying in Patterns Similar to Endogeneity).
© 2022 Copyright FlowView Diagnostics. All rights reserved
